Although not significant, clinical sample analyses indicated that high TFAM expression is potentially associated with poor prognosis in liver cancer and pancreatic cancer (as reported in the Human Protein Atlas, https://www.proteinatlas.org/ENSG00000108064-TFAM/cancer/liver+cancer#LIHC_validation; https://www.proteinatlas.org/ENSG00000108064-TFAM/cancer/pancreatic+cancer#PAAD_TCGA). The gene discussed is TFAM; the disease is medical procedure.